Skip to main content

Table 1 Patients demographics

From: Amelioration of fatigue in chronic dialysis patients with dialysis solution employing electrolyzed water containing molecular hydrogen (H2) and its association with autonomic function balance

 

Group-A HD-responsive type

Group-B chronic type

Group-C fatigue-free type

P

N

38 (40.0%)

11 (11.6%)

46 (48.4%)

 

Age (years)

71.2 ± 8.8

66.9 ± 11.4

72.7 ± 9.8

NS

Male (%)

19 (50.0%)

5 (45.5%)

30 (65.2%)

NS

HD vintage (years)

11.4 ± 10.1

19.4 ± 12.6

7.8 ± 7.8

0.001

A versus C: 0.001

B versus C: 0.045

Modality (HD/OLHDF)

22/16

9/2

31/15

NS

Presence of DM

9 (23.7%)

2 (18.2%)

18 (39.1%)

NS

Body weight (kg)

54.8 ± 13.8

50.4 ± 11.5

55.3 ± 10.8

NS

SBP and DBP (mmHg) before HD

137 ± 20

142 ± 38

141 ± 25

NS

73 ± 13

75 ± 19

76 ± 16

NS

UF volume/session (kg)

2.6 ± 0.8

2.0 ± 0.8

2.3 ± 0.8

NS

History CVD

5 (13.2%)

4 (36.4%)

10 (21.7%)

 

Creatinine (mg/dL)

9.5 ± 2.0

8.6 ± 1.5

9.6 ± 2.2

NS

Hemoglobin (g/dL)

11.1 ± 1.2

11.4 ± 0.7

11.3 ± 1.2

NS

Albumin (g/dL)

3.41 ± 0.26

3.25 ± 0.34

3.42 ± 0.32

NS

  1. HD hemodialysis, OLHDF online hemodiafiltration, DM diabetes mellitus, SBP systolic blood pressure, DBP diastolic blood pressure, UF ultrafiltration, NS not significant